Clinical Trial Update: MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluates MeFAMP as an imaging agent for amino acid transport in brain tumors. The study targets recurrent glioma and brain metastases an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Glioma

Drugs mentioned

• MeFAMP

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Healthy Volunteers, Recurrent Glioma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING